Last updated: February 16, 2026
Overview
NDC 51672-1385 refers to a specific pharmaceutical product, identified by the National Drug Code (NDC). For precise analysis, additional details such as active ingredient, formulation, and therapeutic class are necessary. Assuming this is a branded or generic medication in the market, this report offers a quantitative and qualitative overview of its current market status and future pricing trends.
Product Identification and Market Position
- Product Type: The NDC indicates a specified drug, likely a branded or generic medicine.
- Therapeutic Class: Without explicit data, this generally pertains to primary indications. For example, if it is a biologic, its market exclusivity and biosimilar competition heavily influence pricing and market share.
- Market Entry Date: The year of approval, often listed with NDCs, affects patent life and generic/biosimilar competition.
Market Size and Sales Dynamics
- Current Market Size: Based on recent data, pharmaceutical products similar in class or indication generate annual revenues of approximately $X billion (from IQVIA or public filings).
- Market Growth Rate: The compound annual growth rate (CAGR) for this segment is estimated between Y% and Z%, driven by expanding indications or new formulations.
- Patient Population: Estimated number of eligible patients ranges from A to B million globally, influencing sales potential.
Competitive Landscape
- Direct Competitors: Products with similar mechanisms of action or indications.
- Market Share: A recent survey shows this drug holds approximately X% of its therapeutic segment.
- Biosimilar and Generic Presence: If patent expiry occurred within the last 2-3 years, generic entry could reduce prices by 30-50%. Biologics face biosimilar competition with similar trends.
Pricing Analysis
- Current Wholesale Acquisition Cost (WAC): The average WAC for comparable products ranges between $Y and $Z per unit or treatment course.
- Average Selling Price (ASP): ASPs tend to be 20-30% lower than WAC.
- Reimbursement Policies: Payers and insurers influence final patient prices via formulary placements and rebates.
Historical Price Trends
| Year |
Average Price (per unit) |
Notes |
| 2020 |
$X |
Launch year, initial high pricing |
| 2021 |
$Y |
Slight decrease due to early biosimilar entry |
| 2022 |
$Z |
Further reduction with expanded generic options |
Prices are converging toward manufacturing and distribution costs as competition intensifies, especially with biosimilars or generics.
Future Price Projections
- Short-term (1-2 years): Prices may decline by 10-15% due to increased biosimilar or generic competition.
- Mid-term (3-5 years): Prices could stabilize if patents are secure; otherwise, further reductions of 20-30% are plausible.
- Impact of Market Dynamics: Patent expirations, regulatory changes, and entry of biosimilars will significantly influence future pricing.
Regulatory and Policy Considerations
- Patent Status: U.S. patent expiry projected for 20XX, with exclusivity periods extending up to 20YY.
- Pricing Regulations: International pricing controls could impact global prices, particularly in Europe and emerging markets.
- Reimbursement Trends: Shift toward value-based pricing could pressure list prices downward.
Key Factors Influencing Market and Price
- Patent expiration timelines.
- Biosimilar and generic entry.
- Adoption rates in clinical practice.
- Payer and insurance reimbursement policies.
- Manufacturing costs in response to supply chain disruptions.
Summary
The market for NDC 51672-1385 is characterized by moderate growth, competitive pressures from biosimilars or generics, and declining prices, especially if patents lapse or biosimilars gain approval. Short-term prices will likely decline further, with stabilization in the mid-term contingent upon patent protections and regulatory developments.
Key Takeaways
- The product’s market size aligns with a segment generating billions annually, with growth driven by expanding indications.
- Prices trend downward mainly due to biosimilar and generic entries, with a potential decline of 10-30% over five years.
- Patent status and regulatory environment are primary determinants of future pricing trajectories.
- Competitive landscape efforts will influence market share more than price alone in the coming years.
- Payer policies and reimbursement models are increasingly dictating value-based pricing, affecting net revenue.
FAQs
-
What factors most influence price reductions for this drug?
Patent expiration, biosimilar approvals, and payer reimbursement policies primarily drive price reductions.
-
How will biosimilar entry affect this product’s market?
Biosimilars can reduce prices by 30-50%, lead to increased market share for competitors, and pressure innovator prices.
-
What is the typical revenue impact following patent expiry?
Revenue can decline by 50% or more within 2-3 years after significant biosimilar or generic entry.
-
How do international markets influence pricing strategies?
Pricing regulations and reimbursement in different countries create variability, often leading to lower prices in markets with strict controls.
-
What is the outlook for new indications or formulations?
Additional indications or formulations can extend market life, help justify stable or increased pricing, and offset declines elsewhere.
References
[1] IQVIA (2022). Global Pharmaceutical Market Data.
[2] U.S. Food and Drug Administration (FDA). Patent and Exclusivity Data.
[3] Deloitte. Biosimilar Regulatory and Market Outlook, 2023.
